MINNEAPOLIS and BEIJING, Aug. 26, 2015 /PRNewswire/
-- ECM Medical (ECM), a China-focused
medical device company, announces the acquisition of Greater
China distribution rights for the Interfuse™ System
of novel spinal implants developed and manufactured by Vertebral Technologies,
Inc (VTI).
VTI's breakthrough lumbar interbody fusion system is based
on proprietary modular technology. The InterFuse™ System is designed to enable
spine surgeons to achieve the predictable efficacy of a large, biomechanically
stable footprint, while utilizing familiar, less invasive approaches.
Surgeons are able to optimize conditions for successful
lumbar fusion using VTI's intra-operative assembly™ technology to create an
ALIF-sized footprint but with delivery through a smaller access channel than
with currently available fusion products.
"While our products have approval in 38 markets
worldwide, China is a
key market, said Matt Kyle, CEO,
VTI. "We are excited that our technologies will be available to surgeons
and patients in China."
The initial Greater
China launch will take place in Hong
Kong and Macau in
the fourth quarter of 2015 and in mainland China after
regulatory approvals.
"Orthopedic implants are a key area in our product
portfolio and the Interfuse™ System offers unique benefits over other fusion
products," said Brian Hakim, US
Vice President, ECM Medical. "ECM is pleased to be partnering with VTI to
bring a next generation fusion implant to the China market."
About VTI

For more information about VTI, visit http://www.vti-spine.com
About ECM Medical

For more information about ECM Medical, visit http://www.ecmmedical.com
MEDIA CONTACT INFORMATION
Jonathan Hakim
ECM Medical
T: +86 (10) 5288 7308
MEDIA CONTACT INFORMATION
Matthew Kyle
Vertebral Technologies, Inc.
T: +1 952 912 5400
Published at PR NewsWire
No comments:
Post a Comment